Centrient Pharmaceuticals joins UNGC

Centrient Pharmaceuticals joins UNGC

By: IPP Bureau

Last updated : August 12, 2025 4:51 pm



Reinforcing commitment to ethical and sustainable growth


Centrient Pharmaceuticals, a global leader in sustainable B2B manufacturing of antibiotics, statins, and antifungals, has joined the United Nations Global Compact (UNGC), the world’s largest corporate sustainability initiative.

This move reflects the company’s commitment to responsible business practices and alignment with globally recognized principles on human rights, labour, the environment, and anti-corruption.

As a UNGC participant, Centrient will continue aligning its operations and strategies with the ten universal principles, while supporting broader UN goals, including the Sustainable Development Goals (SDGs).

Centrient is a founding member of the AMR Industry Alliance and has earned Minimized AMR certification from BSI for its Santa Perpetua site in Spain—an independent validation of its strict controls on antibiotic manufacturing emissions to help combat antimicrobial resistance (AMR).

Devvesh Srivastav, Country President, Global HR Director – Tech OP & Regional HR Head – APAC, said: “Joining the UN Global Compact is a proud milestone and a natural progression of our values. It reinforces our commitment to ethical, sustainable growth and to creating a positive impact—not just within our operations, but across the communities we serve. Our people’s dedication to integrity, environmental stewardship, and social responsibility drives our progress every day.”

Centrient has set near-term climate goals approved by the Science Based Targets initiative (SBTi) to reduce environmental impact and build climate resilience. The company aims to expand access to essential medicines to 1.5 billion patients while fostering a diverse and inclusive workplace. Employees actively engage in community initiatives, from tree planting and education to outreach for vulnerable populations, under its Global Purpose Platform, now in its fifth year.

On the governance side, Centrient follows a strong ethical framework guided by its Code of Conduct and Human Rights Policy, aligned with the UN Declaration of Human Rights and core ILO conventions.

By joining the UNGC, Centrient further embeds sustainability into its global strategy, reinforcing accountability to stakeholders, communities, and future generations.

Centrient Pharmaceuticals antibiotics statins antifungals United Nations Global Compact

First Published : August 12, 2025 12:00 am